国家疾控局紧急提醒！诺如病毒已进入高发期，全人群普遍易感，目前尚无特效药物和疫苗可用_腾讯新闻

Novartis Pharma AG: Novartis ribociclib (Kisqali) recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

Novartis Pharma AG: Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer

Novartis Pharma AG: Novartis ranks first in 2024 Access to Medicine Index

俄罗斯癌症疫苗新突破，借鉴新冠疫苗原理，预计在2025年底临床应用_腾讯新闻

首批Novavax疫苗抵台 最快7/8提供接種 - 華視新聞網